The MyD88-dependent pathway also activates the MAPK pathway in cancers that contribute to cancer cell proliferation, resistance to programmed cell death, and synthesis of pro-inflammatory cytokines (via AP-1 activation) [103, 104] [Fig. 11-(2)]. The gene discussed is MYD88; the disease is cancer.